Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 2/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.38 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23493150 | 0.86 | ELANE (0.55) | HSD17B10LMNACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL15679080 | 0.86 | ELANE (0.55) | HSD17B10LMNACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL2625475 | 0.84 | ELANE (0.60) | HSD17B10LMNACYP1A2CYP2C9CYP2C19 | |
| Hydrochloric Acid SCHEMBL30184762 | 0.84 | ELANE (0.53) | HSD17B10LMNACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL285949 | 0.80 | ELANE (0.53) | HSD17B10LMNACYP1A2ELANEALDH1A1 | |
| SCHEMBL9939655 | 0.80 | ELANE (0.53) | HSD17B10LMNACYP1A2ELANEALDH1A1 | |
| SCHEMBL133568 | 0.80 | ELANE (0.53) | HSD17B10LMNACYP1A2ELANEALDH1A1 | |
| Bromide SCHEMBL27527962 | 0.79 | HSD17B10 (0.44) | HSD17B10LMNACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL27540323 | 0.79 | CYP19A1 (0.54) | HSD17B10LMNACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL28460599 | 0.79 | HSD17B10 (0.41) | HSD17B10LMNACYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4007636-B1 | COMPOSITIONS COMPRISING BOVINE ADRENAL MEDULLA 8-22 (BAM8-22) PEPTIDE ANALOGS AND METHODS OF USE | OKYO PHARMA LTD (GG) | 2024-06-19 | — | — | EP | claimed |
| US-20240174715-A1 | PEPTIDE LIBRARIES WITH NON-CANONICAL AMINO ACIDS | INDI MOLECULAR, INC. | 2024-05-30 | — | — | US | claimed |
| US-11919972-B2 | Peptide libraries with non-canonical amino acids | REGENERON PHARMACEUTICALS, INC. (US) | 2024-03-05 | — | — | US | claimed |
| EP-4294820-A1 | CYCLIC CELL-PENETRATING PEPTIDES WITH THREE OR MORE HYDROPHOBIC RESIDUES | Ohio State Innovation Foundation (US) | 2023-12-27 | — | — | EP | claimed |
| EP-4218926-A2 | COMPOSITIONS COMPRISING BOVINE ADRENAL MEDULLA 8-22 (BAM8-22) PEPTIDE ANALOGS AND METHODS OF USE | Okyo Pharma Limited (GG) | 2023-08-02 | — | — | EP | claimed |
| EP-4136102-A1 | LONG ACTING PEPTIDE TYROSINE TYROSINE (PYY) ANALOGS AND METHODS OF USE | I2O Therapeutics, Inc. (US) | 2023-02-22 | — | — | EP | claimed |
| US-20220281915-A1 | COMPOSITIONS COMPRISING BOVINE ADRENAL MEDULLA 8-22 (BAM8-22) PEPTIDE ANALOGS AND METHODS OF USE | OKYO PHARMA LIMITED (GG) | 2022-09-08 | — | — | US | claimed |
| WO-2021212023-A1 | LONG ACTING PEPTIDE TYROSINE TYROSINE (PYY) ANALOGS AND METHODS OF USE | INTARCIA THERAPEUTICS, INC. (US) | 2021-10-21 | — | — | WO | claimed |
| WO-2020230780-A1 | Ras INHIBITORY PEPTIDE | 一丸ファルコス株式会社 | 2020-11-19 | — | — | WO | claimed |
| EP-4610269-A1 | UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE | 3B Pharmaceuticals GmbH (DE) | 2025-09-03 | — | — | EP | disclosed |
| WO-2025109003-A1 | P-CADHERIN LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-05-30 | — | — | WO | disclosed |
| CN-119522233-A | GLP-1/GIP double agonist and preparation method and application thereof | 杭州中美华东制药有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-119080887-A | GLP-1/GIP double agonist and preparation method and application thereof | 杭州中美华东制药有限公司 | 2024-12-06 | — | — | CN | disclosed |
| EP-4007636-B1 | COMPOSITIONS COMPRISING BOVINE ADRENAL MEDULLA 8-22 (BAM8-22) PEPTIDE ANALOGS AND METHODS OF USE | OKYO PHARMA LTD (GG) | 2024-06-19 | — | — | EP | disclosed |
| WO-2005116643-A2 | IDENTIFICATION OF COMPOUNDS MODIFYING A CELLULAR RESPONSE | CARLSBERG A/S (DK) | 2005-12-08 | — | — | WO | disclosed |
| US-6858210-B1 | Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same | LA JOLLA PHARMACEUTICAL CO. (US) | 2005-02-22 | — | — | US | disclosed |
| WO-2004089297-A2 | COMPOUNDS AND METHODS FOR TREATMENT OF THROMBOSIS | SUNTORY PHARMACEUTICAL RESEARCH LABORATORIES, LLC (US) | 2004-10-21 | — | — | WO | disclosed |
| WO-2002100885-A2 | A PENTA- OR TETRAPEPTIDE BINDING TO SOMATOSTATIN RECEPTORS AND THE USE OF THE SAME | NOVASPIN BIOTECH GMBH (DE) | 2002-12-19 | — | — | WO | disclosed |
| EP-0960108-A1 | MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN S.p.A. (IT) | 1999-12-01 | — | — | EP | disclosed |
| WO-1998033788-A1 | MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN S.P.A. (IT) | 1998-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220281915-A1 | COMPOSITIONS COMPRISING BOVINE ADRENAL MEDULLA 8-22 (BAM8-22) PEPTIDE ANALOGS AND METHODS OF USE | CXCL8, CCR8, IL18 | HSD17B10 3772/4885LMNA 3790/4885CYP1A2 4213/4885 |
| US-20240174715-A1 | PEPTIDE LIBRARIES WITH NON-CANONICAL AMINO ACIDS | ARGLU1, NGLY1, VIP | HSD17B10 4662/4885LMNA 3601/4885CYP1A2 2495/4885 |
| US-11919972-B2 | Peptide libraries with non-canonical amino acids | ARGLU1, NGLY1, VIP | HSD17B10 4662/4885LMNA 3601/4885CYP1A2 2495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.